Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02256644 · ClinicalTrials.gov registry record
Genomics of Posttraumatic Stress Disorder in Veterans
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 20,000
- Enrollment target
NCT02256644: Completed study, sponsored by VA Office of Research and Development.
NCT02256644 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 20,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02256644 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 20,000 participants
- Enrollment target
Study Summary
Posttraumatic Stress Disorder (PTSD), as a common and serious mental health condition, affects about 25% of all military personnel that have served in combat. People suffering from PTSD may experience traumatic flashbacks, trouble sleeping, and problems in their relationships. This study is intended to help identify genes that influence and increase the risk of PTSD, to improve ways of detecting and treating the condition in the future. Previous research has studied genes that increase the risk of PTSD, but none of these have included a Veteran-only population. The current study focuses on US Veterans, utilizing the VA Million Veteran Program (MVP) database of approximately 300,000 participants as of August 2014. In this context, participants with PTSD are referred to as "cases" and Veterans without PTSD are referred to as "controls." This project will be done in three stages. The first stage will look at MVP-obtained data and electronic health record (EHR) data to implement methods for identifying combat-exposed case patients with PTSD and combat-exposed control patients without PTSD. The second stage will assemble and validate a study population of 20,000 participants "including 10,000 combat-exposed Veterans with PTSD as cases and 10,000 combat-exposed Veterans without PTSD as controls. The third stage will conduct genetic analyses ("genotyping") comparing the cases to controls, to identify genes associated with increased risk of developing the condition.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2013-12-01 |
| Est. Completion | 2024-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02256644
The ClinicalTrials.gov registry entry for NCT02256644 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02256644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02256644 about?
NCT02256644 is a clinical study titled "Genomics of Posttraumatic Stress Disorder in Veterans". Posttraumatic Stress Disorder (PTSD), as a common and serious mental health condition, affects about 25% of all military personnel that have served in combat. People suffering from PTSD may experience traumatic flashbacks, trouble sleeping, and problems in their relationships. This study is intended...
What is the current status of trial NCT02256644?
This trial is currently completed. The enrollment target is 20,000 participants. The study started on 2013-12-01. Estimated completion is 2024-09-30.
Who is sponsoring clinical trial NCT02256644?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.